Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Compare capital gains tax exposure between ETFs and index funds in retirement, and choose the option with better tax efficiency.
28,430 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
As listings climb in spring 2026, inventory growth making housing is reshaping affordability for buyers, offering mor...
Intel and AMD delivered contrasting Q4 results, highlighting divergent paths: Intel grappling with foundry losses ami...
Two AI pioneers sit on the public markets' doorstep with wall-high expectations. This guide breaks down which giant—a...
PepsiCo reported higher revenue, yet its stock hovered near a 52-week low as investors weighed costs, margins, and gr...
Gordon Ritter argues that AI’s learning loop isn’t a job-killer countdown, but a shift toward human-driven innovation...
Two Senate bills would let six-story apartment buildings use a single interior exit stair, a move that could lower co...
IonQ stands out in the quantum race thanks to its accuracy edge. This article breaks down why ionq: quantum computing...
As memory demand shifts with AI and data-center growth, sandisk stock keeps going up. This deep dive breaks down the ...
SpaceX IPO chatter has investors buzzing about windfalls for insiders and thousands of workers with equity. This repo...
This in-depth analysis examines signet (sig) 2027 earnings, focusing on Q1 2027 results, strategic levers, and what i...
Palvella Therapeutics just saw a notable insider move after a multi-hundred percent rally. This guide breaks down the...